Sanofi (SNY) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to -$2.34.
- Sanofi's EPS (Weighted Average and Diluted) rose 9999.42% to -$2.34 in Q4 2025 from the same period last year, while for Dec 2025 it was -$2.34, marking a year-over-year increase of 9999.42%. This contributed to the annual value of $7.2 for FY2025, which is 5013.79% up from last year.
- As of Q4 2025, Sanofi's EPS (Weighted Average and Diluted) stood at -$2.34, which was up 9999.42% from $2.34 recorded in Q3 2025.
- In the past 5 years, Sanofi's EPS (Weighted Average and Diluted) ranged from a high of $1.1 million in Q2 2025 and a low of -$102093.0 during Q4 2023
- In the last 5 years, Sanofi's EPS (Weighted Average and Diluted) had a median value of $2.41 in 2023 and averaged $170246.2.
- In the last 5 years, Sanofi's EPS (Weighted Average and Diluted) tumbled by 106890493.86% in 2023 and then surged by 722794.97% in 2025.
- Over the past 5 years, Sanofi's EPS (Weighted Average and Diluted) (Quarter) stood at $0.2 in 2021, then surged by 4637.96% to $9.55 in 2022, then plummeted by 1068904.94% to -$102093.0 in 2023, then skyrocketed by 60.64% to -$40180.6 in 2024, then skyrocketed by 99.99% to -$2.34 in 2025.
- Its last three reported values are -$2.34 in Q4 2025, $2.34 for Q3 2025, and $1.1 million during Q2 2025.